TY  - CONF

T1  - Rationale, design and feasibility of conducting a real-world study of outcomes in patients with a history of MI receiving extended DAPT with ticagrelor 60 mg

JO  - PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

PY  - 2020/01/01

AU  - Lesen E

AU  - Hewitt C

AU  - Giannitsis E

AU  - Hedberg J

AU  - Jernberg T

AU  - Lambrelli D

AU  - Lindholm D

AU  - Maggioni AP

AU  - Medin J

AU  - Schultze A

AU  - Sole AA et al

ED  - 

VL  - 29

SP  - 129

EP  - 129

Y2  - 2024/12/22

ER  -